Filing Details

Accession Number:
0001225208-11-014156
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-12 18:45:49
Reporting Period:
2011-05-10
Filing Date:
2011-05-12
Accepted Time:
2011-05-12 18:45:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346102 E John Celentano 345 Park Avenue
New York NY 10154
Svp Hr Public Affairs & Philan No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Acquisiton 2011-05-12 136,955 $28.63 250,440 No 4 M Direct
Common Stock, $0.10 Par Value Disposition 2011-05-12 14,084 $28.63 236,356 No 4 F Direct
Common Stock, $0.10 Par Value Disposition 2011-05-12 22,800 $28.53 213,556 No 4 S Direct
Common Stock, $0.10 Par Value Disposition 2011-05-12 102,706 $28.63 110,850 No 4 F Direct
Common Stock, $0.10 Par Value Disposition 2011-05-10 3,700 $28.81 0 No 4 S Indirect By BMY Savings & Investment Program
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 F Direct
No 4 S Indirect By BMY Savings & Investment Program
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.10 Par Value Executive Option (right to buy) Disposition 2011-05-12 52,474 $28.63 52,474 $17.51
Common Stock, $0.10 Par Value Executive Option (right to buy) Disposition 2011-05-12 26,148 $28.63 26,148 $22.14
Common Stock, $0.10 Par Value Executive Option (right to buy) Disposition 2011-05-12 58,333 $24.74 58,333 $24.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,475 2019-03-02 No 4 M Direct
26,149 2018-03-03 No 4 M Direct
58,334 2016-11-30 No 4 M Direct
Footnotes
  1. Shares withheld for payment of taxes and fees upon exercise of stock options.
  2. This transaction was executed in multiple trades from $28.5900 to 28.6800 . The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades ranging from $28.5200 to $28.5450. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security hold of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. Shares withheld for payment of exercise price upon exercise of stock options.
  5. The reporting person directed the Trustee of the Savings and Investment Plan to sell 3,700.298 shares of Bristol-Myers Squibb common stock held in the Bristol-Myers Squibb Company stock fund.
  6. Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date, which was March 3, 2009.
  7. Twenty-five percnet of the stock option award vest on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2008.
  8. One-third of the stock option award vest on the third, fourth, and fifth anniversary of the grant date, which was December 1, 2006.